osimertinib
astrazeneca
['astrazeneca']
 interesting to see that despite the statement released by many pts didn t get access to osi at progression. this was never a study designed to prove better os!
Medical Oncologist, department of oncology at the University hospital of Geneva (HUG). All opinions expressed here are my own